Cargando…
“H” is not for hydroxychloroquine—“H” is for heparin: lack of efficacy of hydroxychloroquine and the role of heparin in COVID-19—preliminary data of a prospective and interventional study from Brazil
BACKGROUND: COVID-19 pandemic is the major public health problem in the world actually. It’s associated with high morbidity and mortality. To date, no therapeutic measure has a curative potential. Hydroxychloroquine (HCQ) is a drug with immunomodulatory properties that has demonstrated antiviral eff...
Autores principales: | de Oliveira Costa, Renata, Nascimento, Joyce Santos, Reichert, Cadiele Oliana, da Costa, Adriana Pedroso Augusto, dos Santos, Maria Aparecida Pedrosa, Soares, Alberto Macedo, Tomé, Carlos Eduardo Mendonça, Hayden, Ricardo Leite, dos Santos, Cassiano Waldanski, Barreiro, Bruno, El-Khatib, Amer Abdul Basset, de Pádua Covas Lage, Luís Alberto, Pereira, Juliana, Benetti, Mônica Mazzurana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814785/ https://www.ncbi.nlm.nih.gov/pubmed/35120461 http://dx.doi.org/10.1186/s12879-022-07110-1 |
Ejemplares similares
-
Ceftriaxone/heparin/hydroxychloroquine: Thrombocytopenia and off-label use: case report
Publicado: (2020) -
Azithromycin/heparin/hydroxychloroquine: Drug-induced liver injury: case report
Publicado: (2020) -
Angioimmunoblastic T-cell lymphoma and correlated neoplasms with T-cell follicular helper phenotype: from molecular mechanisms to therapeutic advances
por: Lage, Luís Alberto de Pádua Covas, et al.
Publicado: (2023) -
Anti-bacterial/heparin/hydroxychloroquine: Off label use and resistance: case report.
Publicado: (2020) -
Tumor mutation burden involving epigenetic regulatory genes and the RhoA GTPase predicts overall survival in nodal mature T-cell lymphomas
por: de Pádua Covas Lage, Luís Alberto, et al.
Publicado: (2022)